XSTAT® P30 Released
RevMedx is pleased to announce the launch of the FDA cleared XSTAT® P30 – an improved version of our revolutionary hemostatic devices. XSTAT P30 was developed in collaboration with the...
Featured post
XSTAT® P30 Released
RevMedx is pleased to announce the launch of the FDA cleared XSTAT® P30 – an improved version of our revolutionary hemostatic devices. XSTAT P30 was developed in collaboration with the...
XSTAT Profiled in JSOM Newsletter
The XSTAT hemorrhage control device is now featured in the November 1 2020 edition of the Journal of Special Operations Medicine Online Newsletter. This device profile discusses the origins, advantages...
XSTAT 30 Gen 2 Released
We are pleased to announce the launch of XSTAT 30 GEN2 - an improved version of RevMedx's revolutionary hemostatic device that improves ease-of–use and increases effectiveness in the control severe...
TX® Series added to CoTCCC list of recommended limb tourniquets
RevMedx, Inc., a leader in groundbreaking solutions for the control of severe bleeding, today announced that the CoTCCC has added the TX Series ratcheting tourniquets to its list of recommended...
XSTAT featured in Business Insiders "Top 13 Medical Advances"
XSTAT featured in Business Insiders "Top 13 Medical Advances".
VP of Strategic Development, John Steinbaugh interviewed by Tech Briefs
VP of Strategic Development, John Steinbaugh interviewed in Tech Briefs' podcast series, "Here's an Idea™" on XSTAT® and how expanding sponges are changing the world.
XSTAT featured in Deployed Medicine Video
Deployed Medicine video on XSTAT Application. Reviewed and Approved by staff from the Committee on Tactical Combat Casualty Care (TCCC).
RevMedx announces adoption of XSTAT® gunshot wound treatment by emergency responders in Highland Park, Texas
RevMedX XSTAT gunshot wound treatment adopted by Highland Park Texas emergency responders. FDA-cleared hemostatic device for trauma care and hemorrhage control.
